DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard Medical School
  3. HMS Theses and Dissertations
  4. EZH2 Inhibition Induces Endogenous Retroviral Elements and Primes Immunogenicity in Mesenchymal Small Cell Lung Cancer

EZH2 Inhibition Induces Endogenous Retroviral Elements and Primes Immunogenicity in Mesenchymal Small Cell Lung Cancer

Open/View files
THUMMALAPALLI-DOCTOROFMEDICINETHESIS-2018.pdf (1.42 MB)
Date
May 15, 2018
Author(s)
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Thummalapalli, Rohit. 2018. EZH2 Inhibition Induces Endogenous Retroviral Elements and Primes Immunogenicity in Mesenchymal Small Cell Lung Cancer. Doctoral dissertation, Harvard Medical School.
Abstract
Small cell lung cancer (SCLC) is characterized by heterogeneous mesenchymal and neuroendocrine cell states. In particular, aggressive mesenchymal subclones in SCLC harbor characteristic cytokine profiles and activation of innate immune signaling pathways. Recent work has shown that exposure of mesenchymal SCLC tumor cells to IFN-γ leads to production of double-stranded RNA (dsRNA) through transcription of a novel subclass of endogenous retroviruses (ERVs) located in the 3’ UTR of IFN-γ-inducible genes, with this subclass being termed SPARCS (Stimulated 3 Prime Antisense Retroviral Coding Sequences). However, the mechanism of SPARCS de-repression or the consequences of SPARCS dsRNA production for immune signaling and response to immunotherapy in mesenchymal subclones remained unclear. Chromatin profiling using ATAC-seq and ChIP-seq demonstrated increased accessibility of SPARCS loci marked by loss of H3K27 trimethylation in SCLC mesenchymal subclones, suggesting core regulation by the histone methyltransferase EZH2. Neuroendocrine SCLC cells treated with EZH2 inhibition displayed activated SPARCS expression, phenotypic changes suggestive of a mesenchymal state transition, and secretion of mesenchymal-associated cytokines with important roles in immune cell recruitment. EZH2 inhibition also induced endogenous production of IFN-γ and upregulation of antigen presentation machinery, suggesting the development of increased immunogenicity in this state. In addition, SPARCS-high samples across tumor types displayed loss of EZH2, highlighting the potential role of EZH2 in ERV regulation across tumor types. Taken together, these suggest that mesenchymal-associated alterations in histone demethylation lead to induction of ERVs and priming of immunogenicity in SCLC tumor subclones, identifying unique points of intervention which may have important consequences for immunotherapy in small cell lung cancer and other tumors.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
http://nrs.harvard.edu/urn-3:HUL.InstRepos:37006471
Collection
HMS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.